个体化阶梯性药物治疗控制变应性鼻炎症状的优势 评估.

MLA

纪洋洋, et al. “个体化阶梯性药物治疗控制变应性鼻炎症状的优势 评估.” Chinese Journal of Ophthalmology & Otorhinolaryngology, vol. 23, no. 2, Mar. 2023, pp. 141–44. EBSCOhost, https://doi.org/10.14166/j.issn.1671-2420.2023.02.006.

APA

纪洋洋, 许伟民, & 顾凌澜. (2023). 个体化阶梯性药物治疗控制变应性鼻炎症状的优势 评估. Chinese Journal of Ophthalmology & Otorhinolaryngology, 23(2), 141–144. https://doi.org/10.14166/j.issn.1671-2420.2023.02.006

Chicago

纪洋洋, 许伟民, and 顾凌澜. 2023. “个体化阶梯性药物治疗控制变应性鼻炎症状的优势 评估.” Chinese Journal of Ophthalmology & Otorhinolaryngology 23 (2): 141–44. doi:10.14166/j.issn.1671-2420.2023.02.006.